Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8+ T cells.

Redmond WL, Linch SN.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2519-2522. doi: 10.1080/21645515.2016.1193277. Epub 2016 Jul 26.


Interferon-γ Production by Peripheral Lymphocytes Predicts Survival of Tumor-Bearing Mice Receiving Dual PD-1/CTLA-4 Blockade.

McNamara MJ, Hilgart-Martiszus I, Barragan Echenique DM, Linch SN, Kasiewicz MJ, Redmond WL.

Cancer Immunol Res. 2016 Aug;4(8):650-7. doi: 10.1158/2326-6066.CIR-16-0022. Epub 2016 Jun 4.


Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.

Linch SN, Kasiewicz MJ, McNamara MJ, Hilgart-Martiszus IF, Farhad M, Redmond WL.

Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E319-27. doi: 10.1073/pnas.1510518113. Epub 2016 Jan 4.


OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.

Linch SN, McNamara MJ, Redmond WL.

Front Oncol. 2015 Feb 16;5:34. doi: 10.3389/fonc.2015.00034. eCollection 2015. Review.


Common gamma chain (γc) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8(+) T cells.

McNamara MJ, Kasiewicz MJ, Linch SN, Dubay C, Redmond WL.

J Immunother Cancer. 2014 Sep 16;2:28. doi: 10.1186/s40425-014-0028-y. eCollection 2014.


Combined OX40 ligation plus CTLA-4 blockade: More than the sum of its parts.

Linch SN, Redmond WL.

Oncoimmunology. 2014 Mar 17;3:e28245. eCollection 2014.


Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.

Redmond WL, Linch SN, Kasiewicz MJ.

Cancer Immunol Res. 2014 Feb;2(2):142-53. doi: 10.1158/2326-6066.CIR-13-0031-T. Epub 2013 Nov 11.


Interleukin 5 is protective during sepsis in an eosinophil-independent manner.

Linch SN, Danielson ET, Kelly AM, Tamakawa RA, Lee JJ, Gold JA.

Am J Respir Crit Care Med. 2012 Aug 1;186(3):246-54. doi: 10.1164/rccm.201201-0134OC. Epub 2012 May 31.


The role of eosinophils in non-parasitic infections.

Linch SN, Gold JA.

Endocr Metab Immune Disord Drug Targets. 2011 Jun;11(2):165-72. Review.


Mouse eosinophils possess potent antibacterial properties in vivo.

Linch SN, Kelly AM, Danielson ET, Pero R, Lee JJ, Gold JA.

Infect Immun. 2009 Nov;77(11):4976-82. doi: 10.1128/IAI.00306-09. Epub 2009 Aug 24.

Supplemental Content

Loading ...
Support Center